Asia Pacific Insulin Delivery Devices Industry value worth USD 2.54 Bn by 2020Posted by rohan on October 26th, 2017 According to the report Asia Pacific Insulin Delivery Devices Industry, published by Market Data Forecast, The Industry is expected to reach USD 2.54 billion by 2020 from USD 1.64 billion in 2015, growing at a CAGR of 9.10% during the forecast period 2015-2020. Insulin maintains the sugar levels in the blood and essential for the people suffering from type I diabetes & type II diabetes. The development of insulin delivery devices has been encouraged from the past years. These devices are used to deliver the insulin doses via parenteral route rather than oral route of administration. Insulin delivery devices promote absorption rate of insulin into blood stream from the site of injection to execute immediate pharmacological action of insulin. Some of the majorly used insulin delivery devices such as insulin syringes, insulin pens, insulin pen needles, insulin pumps, and insulin jet injectors. Browse Market data tables and in-depth TOC of the Asia Pacific Insulin Delivery Devices Industry to 2020 @ http://www.marketdataforecast.com/market-reports/asia-pacific-insulin-delivery-devices-market-261/ Rising number of pre-diabetic & large diabetic patient population, growing distribution networks of foreign manufacturers in this region, presence of favorable regulatory frameworks, availability of significant medical reimbursements, and growing expansions of advanced medical facilities in certain Asian countries (China & India) are driving the growth of insulin delivery devices Industry in Asia Pacific region. However, low adoption of advanced diabetic technology products, high cost of the manufacturing of products, and lack awareness of diabetic patients about the advanced diabetic treatment solutions are restraining the growth of insulin delivery devices Industry in Asia Pacific region. Asia Pacific insulin delivery devices Industry is segmented based on the type and application. Based on type, the Industry is further sub-segmented as insulin syringes, insulin pens, insulin pen needles, insulin pumps, and insulin jet injectors. Of these, insulin syringes commanded the largest share of Asia Pacific insulin delivery devices Industry in 2015, whereas insulin pens segment is estimated to grow at the highest CAGR during the forecast period 2015-2020. Based on application, the Industry is segmented as type I diabetes and type II diabetes. Free sample of the report is available @http://www.marketdataforecast.com/market-reports/asia-pacific-insulin-delivery-devices-market-261/request-sample On the basis of geographical areas, Asia Pacific insulin delivery devices Industry is segmented as Japan, China, India, Australia, and South Korea. The key players in insulin delivery devices Industry such as, Becton, Dickinson and Company (U.S.), Sanofi (France), Novo Nordisk A/S (Denmark), Julphar (U.A.E.), Eli Lilly and Company (U.S.), Biocon Ltd. (India), Ypsomed AG (Switzerland), Wockhardt Ltd. (India), B. Braun Meselgen AG (Switzerland), and Biodel Inc. (U.S.). Key Points from Table of Contents Overview
Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) Asia PacificInsulin Delivery Devices Industry: Segmentation
Geographical Analysis
Strategic Analysis
Industry Leaders' Analysis Competitive Landscape About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions. Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail:abhishek@marketdataforecast.com
Like it? Share it! More by this author |